13F 申報指南13F 觀念全攻略
什麼是 SEC Form 13F 申報？美股機構大戶持股全攻略
完整解讀 Form 13F 申報規範、1 億美元門檻與 45 天延遲申報機制，學會如何追蹤頂級對沖基金與機構法人持倉動向。
AlphaSMO 權威研究指南閱讀專題
CIK: 0001816307
申報總市值
US$9.6億
US$9.6億
73 檔
32.2%
根據最新整理的 13F 季度數據集，Silverarc Capital Management, LLC 於 Q1 2026 結束時的管理資產規模為 US$9.6億。該機構在本季度申報了 73 檔美股持倉，呈現出該時期的主要投資地圖。
Q1 2026 的申報記錄反映 Silverarc Capital Management, LLC 的板塊替換策略：機構本季推動了 41 筆增持與 48 筆減持，籌碼呈現明顯的結構重組。
整體而言，Silverarc Capital Management, LLC 的前 5 大持股（包含 SPDR SERIES TRUST, 4XC1, DNTH）貢獻了組合市值的 32.2%，形成該機構在 Q1 2026 季度的基本面基石。
| # | 代號 | 標的名稱 | 資產子類別 | 佔比 | 佔比變動 | 持倉量變化 | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | ✓ | Spdr Series Trust | 股票-其他 | 10.75% | -10.75% | EXIT | |
| 2 | 4XC1 | Kalvista Pharmaceuticals Inc | 股票-其他 | 5.91% | -5.91% | EXIT | |
| 3 | DNTH | Dianthus Therapeutics Inc | 股票-其他 | 5.61% | -1.66% | -12.72% | |
| 4 | COGT | Cogent Biosciences Inc | 股票-其他 | 5.16% | -0.01% | +5.54% | |
| 5 | CELC | Celcuity Inc | 股票-其他 | 4.17% | +1.28% | -4.59% | |
| 6 | IMNM | Immunome Inc | 股票-其他 | 4.13% | +0.31% | +64.29% | |
| 7 | KOD | Kodiak Sciences Inc | 股票-其他 | 3.86% | -1.65% | -3.05% | |
| 8 | NUVL | Nuvalent Inc-a | 股票-其他 | 3.71% | -3.71% | EXIT | |
| 9 | ABVX | Abivax Sa-adr | 股票-其他 | 3.44% | -1.09% | -28.34% | |
| 10 | GLUE | Monte Rosa Therapeutics Inc | 股票-其他 | 3.36% | -0.57% | +94.55% | |
| 11 | ERAS | Erasca Inc | 股票-其他 | 3.06% | -0.66% | +40.55% | |
| 12 | ASND | Ascendis Pharma A/S | 股票-其他 | 2.91% | -2.91% | EXIT | |
| 13 | URGN | UroGen Pharma Ltd. | 股票-其他 | 2.76% | +2.22% | -13.56% | |
| 14 | RYTM | Rhythm Pharmaceuticals Inc | 股票-其他 | 2.72% | +0.87% | +125.08% | |
| 15 | PRAX | Praxis Precision Medicines I | 股票-其他 | 2.35% | -0.06% | -13.23% | |
| 16 | ZBIO | Zenas Biopharma Inc | 股票-其他 | 2.27% | -0.93% | — | |
| 17 | SNDX | Syndax Pharmaceuticals Inc | 股票-其他 | 2.12% | +0.64% | +38.28% | |
| 18 | 260 | Centessa Pharmaceuticals-adr | 股票-其他 | 1.89% | -1.89% | EXIT | |
| 19 | SRRK | Scholar Rock Holding CORP | 股票-其他 | 1.70% | -1.70% | EXIT | |
| 20 | ALKS | Alkermes plc | 股票-醫療保健 | 1.66% | -1.04% | — | |
| 21 | ORIC | Oric Pharmaceuticals Inc | 股票-其他 | 1.42% | -0.59% | -1.49% | |
| 22 | IRON | Disc Medicine Inc | 股票-其他 | 1.28% | -0.65% | — | |
| 23 | ✓ | Helix Acquisition CORP Iii | 股票-其他 | 1.25% | +0.05% | — | |
| 24 | XENE | Xenon Pharmaceuticals Inc | 股票-其他 | 1.17% | — | — | |
| 25 | CGON | Cg Oncology Inc | 股票-其他 | 1.15% | -1.15% | EXIT | |
| 26 | IMVT | Immunovant Inc | 股票-其他 | 1.05% | +1.43% | — | |
| 27 | SYRE | Spyre Therapeutics Inc | 股票-其他 | 0.96% | -0.41% | -0.60% | |
| 28 | BIIB | Biogen Inc | 股票-醫療保健 | 0.95% | +0.13% | -32.42% | |
| 29 | GH | Guardant Health Inc | 股票-醫療保健 | 0.93% | +0.63% | +7.18% | |
| 30 | PCVX | Vaxcyte Inc | 股票-其他 | 0.86% | +0.02% | -2.56% | |
| 31 | ✓ | Uniqure NV | 股票-其他 | 0.83% | -0.83% | EXIT | |
| 32 | SVRA | Savara Inc | 股票-其他 | 0.80% | +0.07% | — | |
| 33 | BNTC | Benitec Biopharma Inc | 股票-其他 | 0.78% | +0.17% | -1.91% | |
| 34 | ✓ | Syndax Pharmaceuticals Inc | 股票-其他 | 0.76% | +0.82% | — | |
| 35 | ORKA | Oruka Therapeutics Inc | 股票-其他 | 0.76% | +2.73% | — | |
| 36 | ✓ | Compugen LTD | 股票-其他 | 0.72% | -0.01% | -4.71% | |
| 37 | ✓ | Celcuity Inc | 股票-其他 | 0.63% | -0.63% | EXIT | |
| 38 | TRVI | Trevi Therapeutics Inc | 股票-其他 | 0.62% | +0.69% | -5.56% | |
| 39 | INSM | Insmed Inc | 股票-醫療保健 | 0.60% | -0.22% | -49.69% | |
| 40 | VCYT | Veracyte Inc | 股票-其他 | 0.59% | +1.35% | -49.74% | |
| 41 | CERS | Cerus CORP | 股票-其他 | 0.59% | +0.46% | +12.87% | |
| 42 | CLDX | Celldex Therapeutics Inc | 股票-其他 | 0.58% | -0.58% | EXIT | |
| 43 | CCCC | C4 Therapeutics Inc | 股票-其他 | 0.51% | +0.96% | -4.13% | |
| 44 | CYTK | Cytokinetics Inc | 股票-醫療保健 | 0.48% | -0.48% | EXIT | |
| 45 | CLYM | Climb Bio Inc | 股票-其他 | 0.48% | -0.48% | EXIT | |
| 46 | CMPX | Compass Therapeutics Inc | 股票-其他 | 0.46% | -0.46% | EXIT | |
| 47 | SRZN | Surrozen Inc | 股票-其他 | 0.43% | -0.43% | EXIT | |
| 48 | CTNM | Contineum Therapeutics Inc-a | 股票-其他 | 0.40% | +0.10% | -1.89% | |
| 49 | ✓ | Zura Bio LTD | 股票-其他 | 0.34% | -0.34% | EXIT | |
| 50 | FULC | Fulcrum Therapeutics Inc | 股票-其他 | 0.33% | -0.33% | EXIT |
| # | 代號 | 標的名稱 | 佔比變動 | 持倉量變化 | 異動類型 |
|---|---|---|---|---|---|
| 1 | ERAS | Erasca Inc | +2.4% | +40.55% | 加碼 |
| 2 | ASND | Ascendis Pharma A/S | +1.5% | +153.23% | 加碼 |
| 3 | DNTH | Dianthus Therapeutics Inc | +1.3% | -12.72% | 減碼 |
| 4 | GLUE | Monte Rosa Therapeutics Inc | +1.1% | +94.55% | 加碼 |
| 5 | IMNM | Immunome Inc | +0.8% | +64.29% | 加碼 |
| 6 | RYTM | Rhythm Pharmaceuticals Inc | +0.7% | +125.08% | 加碼 |
| 7 | 4XC1 | Kalvista Pharmaceuticals Inc | +0.5% | +18.51% | 加碼 |
| 8 | 260 | Centessa Pharmaceuticals-adr | +0.3% | +1.78% | 加碼 |
| 9 | SNDX | Syndax Pharmaceuticals Inc | +0.2% | +38.28% | 加碼 |
| 10 | ORIC | Oric Pharmaceuticals Inc | +0.2% | -1.49% | 減碼 |
| 11 | SYRE | Spyre Therapeutics Inc | +0.1% | -0.60% | 減碼 |
| 12 | ELUT | Elutia Inc | 0% | -9.21% | 減碼 |
| 13 | IBIO | Ibio Inc | 0% | +113.21% | 加碼 |
| 14 | EWTX | Edgewise Therapeutics Inc | — | +1.34% | 加碼 |
| 15 | RCKTW | Rocket Pharmaceuticals In-27 | — | — | 不變 |
| 16 | ✓ | Compugen LTD | 0% | -4.71% | 減碼 |
| 17 | CCCC | C4 Therapeutics Inc | 0% | -4.13% | 減碼 |
| 18 | ADGM | Adagio Medical Holdings Inc | 0% | -51.11% | 減碼 |
| 19 | SRZN | Surrozen Inc | -0.1% | -8.31% | 減碼 |
| 20 | RADX | Radiopharm Theranostics LTD | -0.1% | — | 不變 |
| 21 | SION | Sionna Therapeutics Inc | -0.1% | -4.93% | 減碼 |
| 22 | PCVX | Vaxcyte Inc | -0.1% | -2.56% | 減碼 |
| 23 | CTNM | Contineum Therapeutics Inc-a | -0.1% | -1.89% | 減碼 |
| 24 | KOD | Kodiak Sciences Inc | -0.1% | -3.05% | 減碼 |
| 25 | CLDX | Celldex Therapeutics Inc | -0.1% | -6.64% | 減碼 |
| 26 | NXTC | Nextcure Inc | -0.2% | — | 不變 |
| 27 | ABEO | Abeona Therapeutics Inc | -0.2% | +3.38% | 加碼 |
| 28 | CERS | Cerus CORP | -0.2% | +12.87% | 加碼 |
| 29 | TELA | Tela Bio Inc | -0.3% | -14.66% | 減碼 |
| 30 | FULC | Fulcrum Therapeutics Inc | -0.3% | +6.41% | 加碼 |
| 31 | ✓ | Fulcrum Therapeutics Inc | -0.3% | — | 不變 |
| 32 | CMPX | Compass Therapeutics Inc | -0.3% | -18.29% | 減碼 |
| 33 | TRVI | Trevi Therapeutics Inc | -0.3% | -5.56% | 減碼 |
| 34 | GH | Guardant Health Inc | -0.4% | +7.18% | 加碼 |
| 35 | AARD | Aardvark Therapeutics Inc | -0.5% | -88.92% | 減碼 |
| 36 | BNTC | Benitec Biopharma Inc | -0.6% | -1.91% | 減碼 |
| 37 | NUVL | Nuvalent Inc-a | -0.6% | +13.96% | 加碼 |
| 38 | BIIB | Biogen Inc | -0.9% | -32.42% | 減碼 |
| 39 | CGON | Cg Oncology Inc | -0.9% | -53.94% | 減碼 |
| 40 | COGT | Cogent Biosciences Inc | -1% | +5.54% | 加碼 |
| 41 | CELC | Celcuity Inc | -1% | -4.59% | 減碼 |
| 42 | PRAX | Praxis Precision Medicines I | -1% | -13.23% | 減碼 |
| 43 | INSM | Insmed Inc | -1.1% | -49.69% | 減碼 |
| 44 | VCYT | Veracyte Inc | -1.5% | -49.74% | 減碼 |
| 45 | ✓ | Uniqure NV | -1.6% | -30.63% | 減碼 |
| 46 | URGN | UroGen Pharma Ltd. | -2.9% | -13.56% | 減碼 |
| 47 | GUTS | Fractyl Health Inc | -2.9% | -82.71% | 減碼 |
| 48 | ABVX | Abivax Sa-adr | -4.5% | -28.34% | 減碼 |
| 49 | ✓ | Spdr Series Trust | — | NEW | 新建倉 |
| 50 | ZBIO | Zenas Biopharma Inc | — | NEW | 新建倉 |
根據 SEC 官方 Form 13F 申報備案，Silverarc Capital Management, LLC 在 Q1 2026 季度的美股持倉總市值約為 US$9.6億，共申報了 73 個公開持股部位。
在 Q1 2026 季度，Silverarc Capital Management, LLC 按市值排列的前三大核心持股分別為：SPDR SERIES TRUST (10.8%)、4XC1 (5.9%)、DNTH (5.6%)。其中最大持股部位 SPDR SERIES TRUST 佔據整體投資組合約 10.8% 的權重。
精選 AlphaSMO 大戶持股與內部人交易深度分析，提升投資決策勝率
完整解讀 Form 13F 申報規範、1 億美元門檻與 45 天延遲申報機制，學會如何追蹤頂級對沖基金與機構法人持倉動向。
本季最大新建倉標的
SPDR SERIES TRUST
市值: US$1.1億
本季最大獲利了結 / 清倉標的
VRDN
前期市值: US$1084.7萬
在 Q1 2026 季度中，Silverarc Capital Management, LLC 共進行了 89 項持倉異動，包含新建倉 25 個部位、加碼 16 個部位、減碼 28 個部位以及清倉 20 個部位。 其中最大新建倉標的為 SPDR SERIES TRUST。 本季清倉部位包含 VRDN。
本頁面所有持股數據均直接同步自美國證券交易委員會（SEC）EDGAR 官方系統之 13F-HR / 13F-HR/A 季度申報文件。AlphaSMO 透過機器解析 CUSIP 與個股對照，提供 100% 精準對齊的歷史時序數據集，並支援 Schema.org 結構化資料格式。
解析公司高管、董事與 10% 大股東之 Form 4 內部人交易申報，掌握高管自家股票買賣第一手訊號。
深入剖析 5% 股益申報門檻、13D 與 13G 之差異，以及最新 SEC 申報時程規範，洞察機構法人的激進投資動向。